Skip to main content

Peer Review reports

From: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

Original Submission
20 Aug 2009 Submitted Original manuscript
31 Oct 2009 Reviewed Reviewer Report - Dorit Naot
4 Nov 2009 Reviewed Reviewer Report - Susannah O'Sullivan
6 Nov 2009 Reviewed Reviewer Report - Olivia Fromigue
2 Feb 2010 Author responded Author comments - Fabrice Journe
Resubmission - Version 2
2 Feb 2010 Submitted Manuscript version 2
16 Feb 2010 Reviewed Reviewer Report - Susannah O'Sullivan
17 Feb 2010 Reviewed Reviewer Report - Dorit Naot
17 Feb 2010 Reviewed Reviewer Report - Olivia Fromigue
28 Apr 2010 Author responded Author comments - Fabrice Journe
Resubmission - Version 3
28 Apr 2010 Submitted Manuscript version 3
11 May 2010 Reviewed Reviewer Report - Olivia Fromigue
23 May 2010 Reviewed Reviewer Report - Dorit Naot
30 May 2010 Reviewed Reviewer Report - Susannah O'Sullivan
9 Jun 2010 Author responded Author comments - Fabrice Journe
Resubmission - Version 4
9 Jun 2010 Submitted Manuscript version 4
Publishing
17 Jun 2010 Editorially accepted
17 Jun 2010 Article published 10.1186/1471-2407-10-298

You can find further information about peer review here.

Back to article page